Reporter Roger Parloff certainly isn&#x27;t winning any investigative reporting awards here. He seems genuinely confused why Theranos, despite having the ability to use its own technology, might also be using existing technology. One explanation might be that Theranos is collecting blood by industry-standard means so that they could also verify accuracy of their newfangled tests using a subset of that sample.<p>All parties here, from press to company to investors, seem to be maximally full of shit and in massive cover-your-ass mode.